Loss of Stat5a delays mammary cancer progression in a mouse model
Authors:
- 14 June 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (27) , 4335-4339
Abstract
A genetic study was conducted to determine if activated Stat5a contributes to mammary carcinogenesis and to evaluate the mechanism. Similar to human breast cancers, a proportion of mammary adenocarcinomas in the WAP-TAg transgenic mouse model demonstrate constitutive Stat5a/b and Stat3 activation. Stat5a activation is linked to mammary epithelial cell survival and differentiation, and proliferation in hematopoetic cell lineages. Breeding WAP-TAg mice to mice carrying germ-line deletions of the Stat5a gene generated mice with reduced levels of Stat5a. Hemizygous loss of the Stat5a allele significantly reduced levels of Stat5a expression without altering mammary gland development or transgene expression levels. In comparison to mice carrying two wild-type Stat5a alleles, hemizygous loss of the Stat5a allele reduced the number of mice with palpable tumors at 7 months of age (67% from 100%, P3 from 7.6 cm3, P=0.003), delayed first tumor appearance (208 days from 188 days, P=0.01), and increased the apoptotic index in the adenocarcinomas (4.3±0.3 from 1.2±0.2, P=0.016). Neither cell proliferation nor differentiation in the cancers was altered. Decreasing Stat5a activation levels could be a therapeutic approach for reducing survival of breast cancer cells.Keywords
This publication has 31 references indexed in Scilit:
- STAT proteins: novel molecular targets for cancer drug discoveryOncogene, 2000
- Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in miceOncogene, 2000
- The role of STATs in transcriptional control and their impact on cellular functionOncogene, 2000
- STATs in oncogenesisOncogene, 2000
- WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesisOncogene, 2000
- The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RARβ signaling pathways in breast cancer cellsOncogene, 1999
- Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse modelOncogene, 1999
- Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during LactationJournal of Cell Biology, 1999
- Convergence of Progesterone with Growth Factor and Cytokine Signaling in Breast CancerJournal of Biological Chemistry, 1998
- Stat5a is mandatory for adult mammary gland development and lactogenesis.Genes & Development, 1997